Clinical Trial

Prognostic Role of Macular Neovascular Membrane Subtype in Pneumatic Displacement of Macular Hemorrhages

Recruiting
View on ClinicalTrials.gov →
Summary
This study investigates the prognostic value of macular neovascularization (MNV) subtypes in patients treated with pneumatic displacement for submacular hemorrhage. The researchers will compare anatomical and functional outcomes (visual acuity) between PCV, RAP, and other MNV forms within a Caucasian cohort to identify subtype-specific predictors of recovery.
Trial Details
NCT Number NCT07427160
Lead Sponsor Marco Mazzola
Conditions AMD - Age-Related Macular Degeneration
Enrollment 60 participants
Start Date 2025-10-15
Primary Completion 2026-10-15 (estimated)
Study Completion 2026-12-15 (estimated)
Updated on ClinicalTrials.gov 2026-02-23